Search bioRxiv⌕ Search

bioRxiv · 10.1101/2025.07.08.663604

Light stimulation system for measuring pupillary light responses based on Maxwellian view optical system using a retina presentation type viewfinder

Abstract

BackgroundMelanopsin-expressing intrinsically photosensitive retinal ganglion cells (ipRGC) contribute predominantly to non-image-forming effects of light, such as light-induced circadian phase shift, melatonin suppression, and pupillary light reflex. Post-illumination pupil response (PIPR) has been well-used for the evaluation of ipRGC sensitivity for humans since it is able to detect ipRGC function independently from conventional cones. However, pharmacological mydriasis or a specialized light stimulation system, such as the Maxwellian view (MV) optical system, is required to avoid dynamic pupil constriction in the stimulated eye for effective PIPR measurements, which makes these approaches less practical and difficult to implement in standard experimental settings. In this context, we propose the application of a retinal projection viewfinder based on the MV system as a practical approach for measuring PIPR, and evaluate the feasibility of this approach by comparing its performance with a typical LED-based optical system. MethodsTwenty-two healthy participants underwent pupillometry using both the MV-based viewfinder and a typical LED-based system. Monochromatic red and blue light stimuli were presented for durations of 1 and 10 seconds. Pupil responses, including maximum constriction, PIPR amplitude after 6 seconds from the light offset, area under the curve (AUC) values of PIPR, and sustained slopes, were analyzed using a linear mixed-effects model to assess the differences between the two systems. ResultsThe MV-based viewfinder significantly enhanced net PIPR amplitude (p < 0.05) and sustained slope (p < 0.01) during 10-second light stimulation compared to the LED system, demonstrating its capability to effectively measure ipRGC-driven responses. In contrast, no significant differences were observed in the net AUC values. These results highlight that the MV-based viewfinder enables effective PIPR measurements by delivering constant and controlled light stimulation directly to the retina, minimizing the effects of dynamic pupil constriction during light stimulation. ConclusionsThe MV-based viewfinder showed feasibility as an effective method for measuring PIPR without requiring pharmacological dilation or complex optical instrumentation. This approach has strong potential for advancing the assessment of human ipRGC function using pupillary responses.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Eto, T., Yoshiike, T., Utsumi, T., Kawamura, A., Nagao, K., Kuriyama, K., Kitamura, S.. 2025-07-11. Light stimulation system for measuring pupillary light responses based on Maxwellian view optical system using a retina presentation type viewfinder. https://doi.org/10.1101/2025.07.08.663604

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗